Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 7, 2024 | AccuPulse | $27.8M Series A | Shanghai Biopharmaceutical Fund, Shengshi Investment Management | — |
| May 27, 2022 | AccuPulse | $10.0M Series A | Shenzhen Qianhai Capital | — |
| Aug 17, 2021 | Meditrust | $308.7M Series C | Boyu Capital, Janchor Partners | AIHC Capital, Bank of China Group Investment, China Everbright, China Renaissance, CICC Capital, Lake Bleu Capital, Lilly Asia Ventures, Marathon Venture Partners, New Alliance Capital, Sinovation Ventures |